Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 8/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 8/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 7/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.39 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5388597 | 0.76 | NR3C1 (0.45) | KEAP1NFE2L2CHRM2CHRM1CYP2D6 | |
| SCHEMBL5384465 | 0.76 | KEAP1 (0.45) | KEAP1NFE2L2CHRM2CHRM1CYP2D6 | |
| SCHEMBL28061975 | 0.74 | KEAP1 (0.42) | KEAP1NFE2L2CHRM2CHRM1CYP2D6 | |
| SCHEMBL27769779 | 0.73 | POLB (0.47) | KEAP1NFE2L2CHRM2CHRM1CYP2D6 | |
| SCHEMBL27698824 | 0.73 | KEAP1 (0.47) | KEAP1NFE2L2CHRM2CHRM1CYP2D6 | |
| SCHEMBL5381131 | 0.73 | TAAR1 (0.44) | ALDH1A1POLBCYP3A4MAPT | |
| SCHEMBL22257216 | 0.73 | KEAP1 (0.56) | KEAP1NFE2L2CHRM2CHRM1CYP2D6 | |
| SCHEMBL17771882 | 0.71 | KEAP1 (0.58) | KEAP1NFE2L2CHRM2CHRM1CYP2D6 | |
| SCHEMBL5373643 | 0.71 | CHRM2 (0.47) | KEAP1NFE2L2CHRM2CHRM1CYP2D6 | |
| SCHEMBL28062010 | 0.71 | KEAP1 (0.54) | KEAP1NFE2L2CHRM2CHRM1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7238707-B2 | Substituted pentanols, a process for their production and their use as anti-inflammatory agents | SCHERING AG (DE) | 2007-07-03 | — | — | US | disclosed |
| CN-1863775-A | 1- (quinoline-amino) -and 1- (isoquinoline-amino) -substituted pentanols, process for their preparation and their use as anti-inflammatory agents | SCHERING AG (DE) | 2006-11-15 | — | — | CN | disclosed |
| EP-1673344-A1 | 1-(QUINOLINE AMINO) AND 1-(ISOQUINOLINE AMINO)-SUBSTITUTED PENTAN-2-OLS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORIES | Schering Aktiengesellschaft (DE) | 2006-06-28 | — | — | EP | disclosed |
| US-20050143415-A1 | Substituted pentanols, a process for their production and their use as anti-inflammatory agents | SCHERING AG (DE) | 2005-06-30 | — | — | US | disclosed |
| WO-2005035502-A1 | 1-(QUINOLINE AMINO) AND 1-(ISOQUINOLINE AMINO)-SUBSTITUTED PENTAN-2-OLS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORIES | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143415-A1 | Substituted pentanols, a process for their production and their use as anti-inflammatory agents | PTGES, TNF, PTGES2 | KEAP1 2512/4885NFE2L2 252/4885CHRM2 2430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.